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Abstract
To determine the function of VEGF-A in nervous system development, we have utilized the Nestin promoter-driven Cre recombinase
transgene, in conjunction with a conditional and hypomorphic VEGF-A allele, to lower VEGF-A activity in neural progenitor cells. Mice
with intermediate levels of VEGF-A activity showed decreased blood vessel branching and density in the cortex and retina, resulting in a
thinner retina and aberrant structural organization of the cortex. Severe reductions in VEGF-A led to decreases in vascularity and subsequent
hypoxia, resulting in the specific degeneration of the cerebral cortex and neonatal lethality. Decreased neuronal proliferation and hypoxia
was evident at E11.5, leading to increased neuronal apoptosis in the cortex by E15.5. In order to address whether the observed changes in
the structural organization of the nervous system were due to a direct and autocrine role of VEGF-A on the neural population, we
conditionally inactivated the main VEGF-A receptor, Flk1, specifically in neuronal lineages, by using the Nestin Cre transgene. The
normality of these mice ruled out the possibility that VEGF-A/Flk1 signaling has a significant autocrine role in CNS development. VEGF-A
dosage is therefore a critical parameter regulating the density of the vascular plexus in the developing CNS that is in turn a key determinant
in the development and architectural organization of the nervous system.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Vascular Endothelial Growth Factor-A (VEGF-A) and
its receptors (VEGFR1/Flt1, VEGFR2/Flk1, and Neuropi-
lin-1) have been demonstrated to play pivotal roles in blood
vessel development. The lethality of embryos heterozygous
for a targeted null allele of VEGF-A (VEGF-Anull/) (Car-
meliet et al., 1996; Ferrara et al., 1996) and the lethality
associated with the twofold overexpression (Miquerol et al.,
2000) of this growth factor clearly demonstrate that only a
narrow window of VEGF-A expression levels are compat-
ible with the normal development of the cardiovascular
system. The embryonic lethal phenotypes associated with
the deficiencies in VEGF-A receptors further underscore the
essential nature of VEGF-A-induced signaling (Fong et al.,
1995; Kawasaki et al., 1999; Shalaby et al., 1995). The most
severe endothelial defects were documented in Flk1 null
embryos with lethality around embryonic stage 8.5 (E8.5) as
a result of a complete failure of endothelial, hematopoietic,
and endocardial differentiation (Shalaby et al., 1995).
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Fig. 2. Vascularization of the retina visualized by flat-mount, isolectin-B4 immunofluorescence staining. (A) Wild type P7 retina shows regular alternating
pattern of arteries (a) and veins (v). Asterisk denotes developing vascular plexus. (B) Same stage VEGF-Anescre/ retina shows increased density of more
immature vessels (asterisk). (C, D) 3-D illustration of sprouting tips of remodeling endothelial cells in both wild type and VEGF-Anescre/ P7 retinas,
respectively. In both, the tip cells extend long filopodia towards the periphery. However, ectopic filopodia with irregular orientations seem to be more
prominent in mutants (E) Wild type retina at P21 shows normal vessel remodeling and alternating patterns of arteries (a), veins (v), and hyaloid vessel (h).
(F) P21 VEGFnescre/ retina lacks the outer capillary plexus with arteries and veins frequently crossing over in the inner vascular plexus (white arrows). 3-D
reconstruction of the wild type (G) and VEGF-Anescre/ (H) retinal capillary vasculature at P21, respectively. In the wild type retina, larger vessels are visible
in the uppermost vascular layer (retinal fiber layer) viewed from above. A dense capillary plexus develops both in the inner and outer plexiform layer. The
VEGF-Anescre/ retina frequently lacks large parts of the outer retinal plexuses whereas the inner layer, harboring larger vessels, appears rather normal. 3-D
reconstructions of 120 confocal sections demonstrate the almost complete lack of the outer plexiform vascular layer in VEGF-Anescre/ (J) compared with
wild type retinas (I). Individual capillary loops in the intermediate layer and faint regressing profiles in the outer layer can be seen in the mutant retinas
(arrowheads in H and J).
Fig. 1. Recombination specificity of the Nestin-Cre transgenic line. (A) Enhanced Green Fluorescent Protein (EGFP) visualized in an E12.5 Nestin-Cre;Z/EG
double transgenic embryo, in which the two transgenes were inherited from different parents. The embryo shows brain and spinal cord-specific EGFP
expression. (B) Ubiquitous EGFP expression in E12.5 Nestin-cre;Z/EG embryo in which both transgenes were transmitted from the same parent. (C)
Schematic depiction of VEGF-A genomic locus. The black rectangular box marks the position of the XbaI (X)–BglII (B) genomic probe used in Southern
analysis (D). The black “A” represents AccI sites that are not polymorphic in the mouse. The red “A” represents a polymorphic AccI site (RFLP) within Exon
3. (D) Southern analysis of DNA isolated from an 8-month-old VEGF-Anescre/ male. The wt allele lacks while the VEGF-AloxP allele contains the AccI site
within exon 3, therefore generating a 4.8-kb and a 1.4-kb band, respectively. When the loxP-flanked exon 3 was removed from the conditional allele, the
AccI band size changed to 3.2 kb. a, cerebral cortex; b, cerebellum; c, heart; d, stomach; e, spleen; f, liver; g, intestine; h, sperm DNA from testis; i, kidney;
j, bladder.
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Murine VEGF-A is transcribed from a single gene that is
alternatively spliced to produce at least three mRNA spe-
cies, encoding for three proteins: VEGF-A120, VEGF-
A164, and VEGF-A188 (Ng et al., 2001; Tischer et al.,
1991). These VEGF-A isoforms are thought to establish
VEGF-A gradients as a result of their individual binding
capacity to the extracellular matrix. These gradients have
been suggested to play a role in vessel patterning (Ruhrberg
et al., 2002). In addition to alternate splicing, VEGF-A is
controlled by hypoxia and exhibits a dynamic, temporal,
and cell-specific pattern of expression (Dor et al., 2001;
Miquerol et al., 1999).
At the early stages of vascularization of the developing
brain, VEGF-A is expressed in the subventricular zone
(Breier et al., 1992), while its receptors are expressed in
endothelial cells of the perineural capillary plexus and cap-
illary sprouts, infiltrating into the neuroectoderm (Dumont
et al., 1995; Millauer et al., 1993). This expression pattern
is suggestive of a role of VEGF-A and Flk1 in the directed
growth of blood vessels into the developing brain. As the
cortex develops, the neurons are the predominate source of
VEGF-A (Ogunshola et al., 2000). VEGF-A expression is
initially concentrated in the more superficial layers of the
cortex and becomes more diffuse in the deeper layers as the
animal reaches its third postnatal week (Ogunshola et al.,
2000). When vascular remodeling is complete, VEGF-A
expression switches to astroglia that stabilizes the mature
vessels, while neuronal expression is reduced to basal levels
(Ogunshola et al., 2000).
Astrocytic sources of VEGF-A are believed to play a
pivotal role in the recruitment of the vasculature into the
avascular retina of the newborn (Provis et al., 1997; Stal-
mans et al., 2002). The inner retinal vascular layer develops
first, extends toward the periphery, remodels into arteries
and veins, and through a process of sprouting angiogenesis
penetrates the developing retina and forms the outer retinal
vascular layer (Provis et al., 1997; Stalmans et al., 2002).
Several intriguing similarities and interrelationships have
been documented between the developing nervous and vas-
cular systems (Shima and Mailhos, 2000). They both form
dense networks throughout the entire body. Active guidance
systems are operational for both systems, and the initial
primitive networks go through remodeling and maturation
processes in tandem. The two systems share cofactors or
receptors for signaling, such as the Ephrins (Adams and
Klein, 2000; Kullander and Klein, 2002; Orioli and Klein,
1997) and Neuropilin-1. Neuropilin-1 has been demon-
strated to play a pivotal role in neuronal guidance and also
acts as a cofactor for VEGF-A164-mediated Flk1 signaling
(Neufeld et al., 2002; Soker et al., 1998). Furthermore, in
vitro experimentation has demonstrated a more direct role
for VEGF-A/Flk1 in several aspects of neuronal biology.
VEGF-A rescues neuronal cultures from ischemic and glu-
tamate-induced neurotoxicity (Jin et al., 2000; Matsuzaki et
al., 2001) and acts like a neurotrophic factor in stimulating
axonal outgrowth (Sondell et al., 2000). These results sug-
gest that VEGF-A may have a direct autocrine effect on
neurons and glial cells. Exogenous addition of VEGF-A to
the developing CNS results in improved intraneural angio-
genesis, leading to increased neurogenesis and enhanced
nerve regeneration after axotomy (Hobson et al., 2000; Jin
et al., 2002). From a clinical perspective, altered VEGF-A
levels and vascular development have been associated with
neurodegenerative disorders, ischemic cerebral and spinal
cord injury, and diabetic and ischemic neuropathy (Carme-
liet and Storkebaum, 2002). In these situations, VEGF-A is
thought to modulate neuronal development and function
indirectly through its paracrine effects on the vasculature
that in turn provides the necessary neurotrophic support for
proper CNS development and homeostasis.
In this study, we have utilized the neural-specific condi-
tional inactivation of both VEGF-A and its main receptor
Flk1, to distinguish between autocrine versus paracrine
modes of VEGF-A action in the nervous system. We have
concentrated our analysis on retinal and cortical develop-
ment in the mouse to address the potential functions of
VEGF-A in these tissues. We have utilized the Nestin-Cre
transgenic line in combination with a conditional and a
hypomorphic VEGF-A allele to specifically lower VEGF-A
levels in the developing CNS (Damert et al., 2002; Gerber
et al., 1999; Tronche et al., 1999). To address the potential
autocrine role of VEGF-A, Flk1 was conditionally inacti-
vated by the Nestin-Cre transgene.
Through this genetic approach, together with a detailed
high resolution analysis of the vascular endothelium, we
have determined the phenotypic consequences of decreasing
VEGF-A activity in cortex development and revealed spe-
cific alterations in the vascularization of the retina. This
study suggests a dominant paracrine role for this factor in
the structural organization of the nervous system.
Materials and methods
Mice
The Tie2-Cre, Nestin-Cre, Z/EG, conditional and hypo-
morphic VEGF-A mouse lines have all been previously
reported (Kisanuki et al., 2001; Tronche et al., 1999; Novak
et al., 2000; Gerber et al., 1999; Damert et al., 2002). Wild
type ICR mice were obtained from Harlan, USA. All ex-
periments were performed in accordance with protocols
approved by our Animal Care Committee. Generation of the
targeting vector and ES cell lines used to produce the
conditional Flk1 allele has been described previously
(Muhlner et al., 1999). R1 ES cells harboring the condi-
tional Flk1 allele (see Supplementary Data) were injected
into C57BL/6 blastocysts in order to generate chimaeric
mice. One ES cell line (2C6) gave rise to chimaeric mice
that transmitted the floxed Flk1 allele through the germline,
and this mouse line was maintained on a mixed C57BL/6-
CD1 background.
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Southern and PCR analysis
Genomic DNA isolated from adult male VEGF-Anescre/
organs and yolk sacs from E9.5 embryos were subjected to
AccI enzymatic digestion (NEB, Canada), separated by aga-
rose gel electrophoresis transferred to a Hybond-N mem-
brane (Amersham-Pharmacia Biotech, Canada). The mem-
brane was probed with an XbaI–BglII probe (corresponding
to intron2 sequences upstream of Exon3) isolated from a
plasmid containing an 18-kb genomic VEGF-A clone en-
compassing exons 1–4 of the murine VEGF-A locus (Fer-
rara et al., 1996). PCR analysis of the Nestin-Cre, Tie2-Cre,
conditional and hypomorphic VEGF-A alleles have all been
previously reported (Damert et al., 2002; Gerber et al.,
1999; Kisanuki et al., 2001; Tronche et al., 1999). Geno-
typing of the conditional Flk1 allele was performed on
purified tail or embryonic yolk-sac DNA by using the
primer pair UMCRE1 and UMCRE2 (oligonucleotide se-
quences 533-UMCRE1-GGGTGCCATAGCCAATCA-
AAGACGC; UMCRE2-TATCGGTGTTCCCCTGGGTGT
GTGG) with the following PCR conditions: 1: 94°C for
90 s, 2: 94°C for 30 s; 3: 53°C for 40 s, 4: 65°C for 60 s;
39 to step 2. All PCR reactions were carried out by using
PCR reagents from Bio Basics Inc. (Canada) according to
manufacturer’s instructions.
Histological analysis, TUNEL assay, BrdU and Hypoxia
immunohistochemistry
Embryos from Nestin-Cre, VEGF-Ahypo/  VEGF-
Alox-P/lox-P breedings were either dissected in ice-cold PBS,
or brains and eyes were harvested at birth, P7, or P21 and
fixed overnight at 4°C in 4% PFA. Samples for histological
analysis were dehydrated through a graded alcohol series
and embedded in paraffin wax as previously described
(Haigh et al., 2000). Seven-micrometer sections were depar-
affinized and either stained with Harris’ Haematoxylin and
Eosin or were subjected to either TUNEL assays, immuno-
histochemistry, or isolectin-B4 immunofluorescence analy-
sis. TUNEL analysis was performed by using the in situ cell
death detection kit (Roche, 1684809) according to the man-
ufacturer’s instructions. Prior to sacrificing the pregnant
female mice, they were IP injected with a mixture of 50 mg
BrdU (Sigma, B-9285) and 60 mg of pimonidazole hydro-
chloride (Hypoxyprobe hypoxia assay kit; NPI Inc., Bel-
mont, MA) per kg mouse body weight (reagents were dis-
solved in 10 mM Tris/HCl, pH 7.4, 0.8% NaCl, 0.25 mM
EDTA). Pregnant females were sacrificed 2 h following
injections, and embryos were harvested and processed. Im-
munohistochemical analysis was performed as previously
published by using an anti-BrdU antibody (Roche, Cat. No.
1170376) and an antibody raised against pimonidazole ad-
ducts (NPI, Inc.) (Behrens et al., 2003; Lee et al., 2001).
GFP, Isolectin-B4 analysis and confocal fluorescence
microscopy
EGFP from the Nestin-Cre, Z/EG double transgenic em-
bryos was detected as previously described (Novak et al.,
2000). Embryos and eyes were fixed in 4% PFA in PBS at
4°C overnight and washed in PBS. Forebrains were dis-
sected clean from surrounding tissue, labeled as described
below, and flat-mounted ventricular side up. Retinas were
dissected and cleared from retinal pigment epithelium,
sclera, and hyaloid vasculature. Retina and forebrain sam-
ples were permeabilized in PBS containing 1% BSA and
0.5% Triton X-100 at 4°C overnight. They were rinsed in
PBS, washed twice in PBlec (PBS, pH 6.8, containing 1%
Triton X-100, 0.1 mM CaCl2, 0.1 mM MgCl2, 0.1 mM
MnCl2), and incubated in biotinylated isolectin B4 (Ban-
deiraea simplicifolia, Sigma L-2140), 20 g/ml in PBlec at
4°C overnight. Following five washes in PBS, the samples
were incubated with streptavidin conjugates (Cy3, Sigma)
diluted 1:100 in PBS containing 0.5% BSA and 0.25%
Triton X-100 at 4°C for 6 h. After washing and brief
postfixation in 4% PFA, the retinas were directly flat
mounted by using Mowiol supplemented with anti-bleach-
ing agent DABCO (Sigma). Flat mounting of retinas was
achieved by making four radial incisions. Retinas were
analyzed by conventional fluorescence microscopy using a
Nikon E1000 microscope equipped with a digital camera
(Nikon Coolpix 990) and by confocal laser scanning mi-
croscopy using a Leica LCS NT. Digital images were pro-
cessed by using Adobe Photoshop 6. Computer modeling of
the retinal vasculature was performed with OpenLab soft-
ware (version 2.0.7).
Vessel and neuronal quantification
Vessel quantification was performed by randomly count-
ing branchpoints and calculating averages from five differ-
ent randomly chosen fields from three separate mice per
genotype at 160 magnification. Neuronal numbers and
their proliferation indices were quantified by counting
haematoxylin-stained neuronal nuclei and/or BrdU-labeled
nuclei at 500 magnification in randomly chosen fields in
the superficial cortical layers of the P21 brain and the
periventricular zone of the developing cortex. Counts were
performed on serial sections throughout representative mu-
tant and control brains and embryos.
Results
Nervous system deletion specificity of the Nestin-Cre
transgenic mouse line
Given the strong dosage sensitivity of the developing
cardiovascular system to alterations in VEGF-A levels, one
of the most critical initial issues was to confirm the exci-
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sion-specificity of the Nestin-Cre transgene (Tronche et al.,
1999). Therefore, Nestin-Cre transgenic mice were crossed
with Z/EG reporter partners (Novak et al., 2000). In the
double transgenic offspring, the Cre recombinase-mediated
excision of the reporter transgene switched lacZ to En-
hanced Green Fluorescent Protein (EGFP) expression,
which gave a convenient readout of Cre expression speci-
ficity. E9.5 double transgenic embryos showed strong EGFP
expression in the neuroectoderm, demonstrating the early
onset of Cre activity in the CNS (data not shown). Three
days later, E12.5 embryos showed strong EGFP expression
exclusively along the entire length of the developing spinal
cord and brain (Fig. 1A). To further characterize this line,
Nestin-Cre; Z/EG double transgenic males or females were
crossed with wild-type partners. Surprisingly, the resultant
double transgenic embryos were ubiquitously green, indi-
Fig. 3. Neuronal acellularity in the wild type and VEGF-Anescre/ cerebral cortex correlates with decreased sprouting angiogenesis. H&E histological staining
through the cortical layers of wild type (A) and VEGF-Anescre/ (B) P21 mice. (C) and (D) are higher power images of the corresponding inserts showing
the position and the cellularity of layers I–III. (E, F) Isolectin-B4 immunofluorescence staining on adjacent sections revealed decreased vascular density and
decreased sprouting complexity in the P21 VEGF-Anescre/ cortex (F) compared with a littermate wild type control (E). Scale bars represent 50 m.
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Fig. 4. Cortical neuronal degenerative phenotype of VEGF-A nescre/hypo neonates. (A) Posture of wild type and VEGF-Anescre/hypo neonates (asterisk). Cranial
morphology of wild type (B) and VEGF-Anescre/hypo (C) newborns. The size of the wild type (D) and VEGF-Anescre/hypo (E) cerebral cortex and their
corresponding pial vasculature (F and G, respectively). H&E staining of wild type (H, L, P) and VEGF-Anescre/hypo (I, M, Q) cortical sections. Note the
expansion of the lateral ventricles (I). Isolectin-B4 endothelial immunofluorescence staining of wild type (J, N, R) and VEGF-Anescre/hypo cortex (K, O, S).
Note the overall decrease in endothelial content and lack of sprouting angiogenesis from the pial vasculature in the mutant brain (O vs. N), CPL, cortical
plate; MZ, marginal zones; VZ, ventricular zone; SVZ, subventricular zone; MZ, marginal zone; CPL, choroid plexus; IZ, intermediate zone. Scale bars
represent 50 m.
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cating that ectopic Cre protein expression had mediated a
premature excision of the reporter allele, presumably during
gametogenesis (Fig. 1B). This unexpected “ectopic” germ-
line excision of the reporter allele excluded the use of the
Nestin-Cre transgenic mouse line for generating a complete
nervous system-specific knockout of VEGF-A, while keep-
ing the status of this gene wild type in other tissues. This is
necessary, since the ubiquitous deletion of one of the con-
ditional VEGF-A alleles leads to early embryonic lethality
(Carmeliet et al., 1996; Ferrara et al., 1996).
To generate mice that have deleted one VEGF-A allele
specifically in the developing nervous system, Nestin-Cre
hemizygous transgenic mice were crossed with partners
homozygous for the VEGF-A conditional allele (VEGF-
AloxP/loxP) (Gerber et al., 1999). Double transgenic Nestin-
Cre; VEGFloxP/ mice (hereafter referred to as VEGF-
Anescre/ mice) were born with the expected Mendelian
frequency and showed no overt phenotypical or behavioral
abnormalities under normal conditions (data not shown). To
determine the specificity and efficiency of Nestin-Cre-
mediated deletion of the floxed VEGF-A allele in the double
transgenic mice, Southern analysis was performed on tis-
sues isolated from an 8-month-old adult male mouse. This
analysis depicted the high degree of deletion of the condi-
tional VEGF-A allele in the cerebrum and cerebellum (a and
b, respectively, in Fig. 1D). All other tissues examined with
the exception of sperm isolated from the testis of this mouse
showed no or only minimal excision of this allele (Fig. 1D).
The complete excision of the conditional VEGF-A allele in
sperm was consistent with our characterization of Nestin-
Cre expression using the Z/EG reporter and further sup-
ported our initial observations that the Cre protein is also
expressed during gametogenesis.
Delays in vascular remodeling and outer retinal vascular
layer deficiencies in VEGF-Anescre/ mice
At postnatal day 1 (p1), we did not observe any differ-
ences in vessel invasion into the inner retinal layer from the
optic disc in the VEGF-Anescre/ mice compared with wild
type controls (data not shown). By p7, the wild-type vas-
culature has almost reached the periphery and has com-
menced vascular remodeling and specification resulting in
an alternating pattern of properly interconnected branching
arteries and veins (a and v in Fig. 2A). The retinas from
VEGF-Anescre/ mice show normal vascular migration and
extension into the periphery compared with controls. How-
ever, substantial delays in vascular remodeling are indicated
by the abnormally high vascular plexus density ahead of the
developing arteries (asterisk in Fig. 2B). Occasionally, ar-
teries and veins cross-over (arrows in Fig. 2B and F). 3-D
computer generated shadow projections of isolectin-B4-la-
beled endothelium show filopodial extension toward the
periphery in both wild type and VEGF-Anescre/ retinas at
p7 with slight increases in aberrantly orientated filopodia in
the heterozygous VEGF-A mutant (arrowheads in Fig. 2C
and D). Between p5 and 3 weeks of age, the retinal vascu-
lature invades the retina and forms a complex tripartate
vascular plexus “sandwiching” parts of the retina between
an inner and outer vascular layer (Fig. 2G). In the most
affected mutant retinas, there was a clear lack of develop-
ment of the outer retinal layer in VEGF-Anescre/ mice by
p21 of development (Fig. 2E–J). At p21, the control retina
displays a normal alternating pattern of arteries (a) and
veins (v), and the veins are never directly connected to
capillaries of the inner retinal plexus but receives input from
the outer capillary plexus (Fig. 2E, G, and I). Mutant p21
VEGF-Anescre/ retinas that lacked a proper outer vascular
plexus (Fig. 2F, H, and J) were extremely thin and showed
signs of degeneration (data not shown). Not all retinas were
as severely affected: retinal thickness correlated with the
degree of formation of the outer capillary plexus. In keeping
with the retinal degenerative phenotype, we also observed a
strong increase in microglia/macrophage numbers near the
developing veins in some mutant retinas already at p7 (Sup-
plementary Data, Figure I). This increased microglial den-
sity is consistent with gliosis and retinal degeneration. The
lack of an outer vascular plexus in affected mice is also
reflected in the numerous connections of the inner capillary
plexus to veins, and frequently, arteries and veins continue
to crossover (white arrow in Fig. 2F). 3-D computer gen-
erated reconstructions of the isolectin-B4 immunofluores-
cence images of the retinal vasculature show that in the
control retina there are normal larger vessels in the outer
plexiforme layer below the inner retinal layer (Fig. 2G). In
the most affected mutant p21 retinal vasculature, 3-D over-
views show a normal inner vascular layer but a clear lack of
development of the outer plexiforme layer (Fig. 2H). Com-
puter-assisted side views (Z-views) of reconstructions of
120 serial confocal images unequivocally demonstrate the
differences in retinal vasculature between wild type and the
mutant (Fig. 2I and J).
Altered vascular development leads to cortical
acellularity in VEGF-Anescre/ mice
Gross inspection of wild type and VEGF-Anescre/ brains
revealed no overall changes in patterning. We observed,
however, a substantial reduction (approximately 20–30%)
in overall cortical brain size in VEGF-Anescre/ brains com-
pared with age- and sex-matched wild type littermates by
p21 (data not shown). Histological inspection of the mutant
cortex revealed an overall decrease in neuronal cellularity,
particularly in the more superficial cortical layers I–III (Fig.
3A–D). To quantitate this decrease, we counted randomly
selected fields in these regions at 500 magnification every
fifth section (35 m) from five different serial sections
throughout representative mutant and control brains. Neu-
ronal counts at p21 revealed a mean of 53  18 neurons in
the control cortical layer I and 19  8 neurons in the
VEGF-Anescre/ cortex. Cortical layers II and III showed
even greater differences in neuronal cellularity with wild
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type neuronal counts being on average 104  35 and mu-
tants counts being 35 10 cortical neurons per optical field.
Isolectin-B4 immunofluorescence analysis of brain sections
revealed an overall decrease in vascular density and sprout-
ing angiogenesis that was not only limited to the cortex but
also present in the cerebellum, brain stem, and spinal cord
(data not shown).
Severe reductions in VEGF-A activity causes neuronal
degeneration of the cortex
To further decrease VEGF-A levels below those ob-
tained in VEGF-Anescre/ mice in the developing nervous
system, a hypomorphic VEGF-A allele (VEGF-Ahypo)
(Damert et al., 2002) was bred into this genetic system.
Since mice heterozygous for the hypomorphic allele are
viable, Nestin-Cre; VEGF-Ahypo/ double transgenic males
were first generated and then mated with VEGF-AloxP/loxP
partners to produce Nestin-Cre; VEGF-AloxP/hypo triple
transgenic offspring. In these mice, one of the VEGF-A
alleles is specifically deleted in the developing nervous
system, while the other is hypomorphic throughout the
mouse. Therefore, outside the nervous system, the VEGF-A
status of these animals is functionally equivalent with that
of the VEGF-A/hypo viable genotype. Hereafter, these off-
spring are designated as VEGF-Anescre/hypo mice.
VEGF-Anescre/hypo mice were born alive in the expected
Mendelian ratio, but they could not survive beyond p1.
These neonates were readily identifiable phenotypically
from their wild type littermates by their altered cranial
morphology and spastic uncontrolled movements (Fig.
4A–C, and data not shown). They displayed an inability to
remain upright when placed in the prone position likely as
a result of a lack of muscular coordination (Fig. 4A) and
were unable to feed as was evidenced from the absence of
milk in their stomachs. They died of dehydration within
24 h (Fig. 4A, and data not shown). Dissections of wild type
and mutant p1 brains show a clear difference in the size of
cerebral cortex in the mutant VEGF-Anescre/hypo mice (Fig.
4D and E). Higher power magnification of mutant cortices
showed an absence of pial vasculature and evidence of
cortical degeneration compared to control littermate cortices
(Fig. 4F and G). Closer histological inspection of the mutant
brain revealed altered cortical neuronal organization and
accompanying neuronal degeneration mainly in the subven-
tricular zone (SVZ in Fig. 4Q). In contrast, the wild type
brain showed typical well-organized cortical zones (Fig.
4H, L, and P). In addition to the anterior cortical degener-
ative phenotype, there was also evidence of hydrocephalus
(excess cerebrospinal fluid) and altered choroid plexus (cp)
development and function (Fig. 4I). Isolectin-B4 immuno-
fluorescence analysis of the cortical brain vasculature dem-
onstrated a severe deficiency in vascular development in
both the superficial levels of the cortex near the marginal
zone (mz) and cortical plate (cpl), and in the deep ventric-
ular zone (vz) in the mutant VEGF-Anescre/hypo brain com-
pared with controls (Fig. 4K, O, and S, compared with wild
type seen in Fig. 4J, N, and R). Vessel analysis of other
regions of the CNS showed similar defects in vessel density;
however, no obvious neurodegenerative phenotypes were
evidenced as in the cerebral cortex (data not shown).
Altered VEGF-A levels cause dosage-dependent
reductions in vessel density
In order to gain insights into how altered VEGF-A levels
affect vessel patterning in the p1 cortex, we examined thick
vibratome sections using immunofluorescence analysis of
the isolectin-B4-labeled vasculature. Average vessel
branching point density was determined for the wild type,
VEGF-Anescre/, VEGF-Ahypo/, and VEGF-Anescre/hypo ge-
notypes as 5430 (100%), 3386 (40%), 3196 (37%), and 477
(9%) branch points/mm2 (Fig. 5A–D). The reductions in
branch points resulted in greater distances between blood
vessels. In the wild type, there is an average distance of 50
m between vessels that rises to 70 m in the VEGF-
Anescre/ and VEGF-Ahypo/ samples and is up to 100 m in
the most severe VEGF-Anescre/hypo cortex in vascularized
areas. The mutants also showed changes in sprouting endo-
thelial tip-cell morphology in terms of filopodial extensions.
In the wild type, long filopodia extend in a directional
manner only from the leading endothelial tip-cell (insert in
Fig. 5A). In the VEGF-Anescre/ cortices, the sprouting tip
cell morphology was quite normal; however, small ectopic
non-tip-cell filopodia could be observed in large vessels
(insert, Fig. 5B; and data not shown). In the VEGF-Ahypo/
cortex, there were fewer tip-cell filopodia extensions that
appeared longer and less spread out than in the wild-type
controls, but showed little evidence of ectopic extensions
(insert, Fig. 5C). In the VEGF-Anescre/hypo mutants, very
little tip-cell filopodial sprouting could be observed at all,
and when present on tip-cells, they appeared long and spa-
tially confined as in the hypomorphic situation. The vessels
that did exist in the double mutant appeared irregular with
some small ectopic sprouting from the larger vessels (insert
in Fig. 5D, and data not shown). In terms of the eye vas-
culature, there was also a clear absence of sprouting angio-
genesis into the p1 inner plexiforme layer of the retina in the
VEGF-Anescre/hypo mutants compared with the wild-type lit-
termates. However, given the lethality of the double mutants
at this time point, no further analysis could be performed
(data not shown).
Given the early onset of Cre activity in the Nestin-Cre
transgenic line (E9.5), vascular density was also exam-
ined in both the affected forebrain region and the nonde-
generated hindbrain region at E10.5 in all four genotypes
(Fig. 5 and Supplementary Data, Figure II). In the wild-type
forebrain vasculature as seen from the ventricular side,
normal branching and vessel spacing is observed with long
filopodial extensions arising solely from the sprouting tip-
cell (Fig. 5E and F). The average number of branch points
for the wild-type, VEGF-Anescre/, and VEGF-Ahypo/ fore-
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Fig. 6. Histological analysis of the forebrain of wild type (1st and 3rd rows, A–E and K–N) and VEGF-Anescre/hypo (2nd and 4th rows, F–J and O–S) E11.5 and 13.5 embryos
for morphology (H&E staining, 1st column), cellularity (H&E staining, 2nd column), vascularization (Isolectin-B4 immunofluorescence, 3rd column), hypoxia
(anti-pimonidazole immunohistochemistry, 4th column), and proliferation (BrdU labeling, 5th column). PVZ, periventricular zone. Scale bars represent 50 m.
Fig. 5. Isolectin-B4 endothelial cell immunofluorescence staining of the p1 cortex and E10.5 flat-mount forebrains from four genotypes producing different levels
of VEGF-A. In the order of increasing vascular defect severity: (A) wild type, (B) VEGF-Anescre/, (C) VEGF-Ahypo/, and (D) VEGF-Anescre/hypo (160
magnification). Inserts are 630 magnifications of leading edge sprouting-tip endothelial cells. Note that in the wild type cortex, long filopodia extend from the tip
cell (insert in A) and in VEGF-Anescre/ (insert in B) tip cell morphology is similar to the wild type. In VEGF-Ahypo/ samples (insert in C), the filopodia number
is slightly decreased and is most severe in the VEGF-Anescre/hypo cortex where very few filopodia were observed (insert in D). Vascular plexus (E) and sprouting
endothelial cells (F) of wild type E10.5 forebrain. Note the normal endothelial branching and patterning and long bundles of filopodia extending from distinct regions
of the developing tips, while the vessel surface remains relatively smooth and lacks non-tip cell filopodial extensions (white arrows). Vascular plexus (G) and
sprouting endothelial cells (H) of VEGF-Anescre/ and VEGF-Ahypo/ (I, J) forebrain. Note that these genotypes show intermediate levels of vessel branching
densities and patterning defects compared with wild type. They also show filopodial extensions from ectopic non-tip cells (white arrowheads in H and J). In the
VEGF-Ahypo/ forebrain (J), the ectopic and tip-cell filopodia extensions are shorter than wild type and VEGF-Anescre/ filopodia. In VEGF-Anescre/hypo forebrains
(K), the degree of vascular branching becomes markedly decreased. The length of filopodia extensions is decreased and ectopic extensions are prevalent and have
a much more irregular surface and tuft-like morphology (L). Scale bars represent 100 m.
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brains was 221 (100%), 183 (83%), and 164 (74%) branch
points/mm2, respectively. As a result of this altered branch-
ing, the distance between vessels was also increased in a
similar way as in the p1 cortex (Fig. 5G and I). In both
heterozygous mutant samples, ectopic filopodial extensions
are observed branching off on non-tip endothelial cells
(arrowheads in Fig. 5H and J). In the VEGF-Anescre/hypo
mutants, branching density fell further still to 87 (39%)
branchpoints/mm2 and displayed the accompanying in-
creased distance between vessels (Fig. 5K). The vasculature
in the double mutant showed non-tip cell filopodial exten-
sions and in general the vasculature seemed much more
irregular than either heterozygous mutant or wild type lit-
termates (Fig. 5L). Overall, despite the differences in vessel
branching and filopodial extensions, at this stage the vessel
diameter remained the same in all four genotypes examined.
Altered vessel density causes abnormal neuroectoderm
development
Histological, isolection-B4 vessel, hypoxia, apoptosis,
and proliferation analyses were performed on adjacent sec-
tions of VEGF-Anescre/hypo mutant and wild-type embryos at
E11.5, E13.5, and E15.5 time points to determine the onset
of neuronal degeneration and the cellular mechanisms be-
hind this phenotype (Figs. 6 and 7). At E11.5, no overt
histological difference was observable between control and
mutant (Fig. 6A, B and F, G, respectively). This is despite
the clear differences seen in sprouting angiogenesis already
present within this region (Fig. 6C and H). The hypoxia
marker pimonidazole hydrochloride (Lee et al., 2001; Varia
et al., 1998) was used to determine any differences in tissue
hypoxia between control and mutant sections that correlated
with the altered vessel phenotype. Clear differences were
observed in the level of tissue hypoxia between controls and
mutant samples, while no differences in neuronal apoptosis
were observed by TUNEL analysis in the same tissues (Fig.
6D and I, and data not shown). The decreased vessel density
and increased tissue hypoxia did have effects on neuronal
proliferation in the periventricular zone (PVZ) of VEGF-
Anescre/hypo mutant forebrains compared with controls (Fig.
6E and J). BrdU labeling demonstrated a 25% reduction in
the numbers of proliferating neurons in the mutant periven-
tricular zone (data not shown). The first clear histological
evidence of degeneration became apparent in the mutant
forebrain at E13.5 (Fig. 6P). Altered vessel densities and
continued hypoxia resulted in a 60% decrease in the number
of proliferating periventricular neurons in the mutant fore-
brains but still demonstrated no differences in neuronal
apoptosis compared with controls (Fig. 6N and S, and data
not shown). At E15.5, overt and specific anterior cortical
neuronal degeneration was observed in histological sections
of the VEGF-Anescre/hypo mutant brains (Fig. 7A and B). The
decreased vessel density and lack of sprouting angiogenesis
became more pronounced by E15.5, and there was ubiqui-
tous hypoxia seen throughout the CNS in the mutant com-
pared with controls (Fig. 7C, D and E, F, and data not
shown). At this stage, TUNEL analysis revealed a large
number of apoptotic neurons in the mutant cortex compared
to controls (Fig. H vs G). The neuronal degeneration there-
fore starts between E13.5 and E15.5 and becomes more
pronounced as development proceeds, with the first visible
external differences in cranial morphology observable by
E17.5 (data not shown).
Conditional inactivation of Flk1 in the developing
nervous system does not result in overt changes in
neuronal development
The specific aberrations in the development of cortical
layers in the VEGF-Anescre/ mice and the severe neuronal
degenerative phenotype observed in the VEGF-Anescre/hypo
mutants raised the possibility that the putative autocrine role
of VEGF-A in neuronal development may also have con-
tributed to these phenotypes. To examine this possibility,
we performed a nervous system-specific inactivation of the
main signaling VEGF-A receptor, Flk1, using the Nestin-
Cre transgenic line and a conditional Flk1 allele (fully
characterized in vitro; Muhlner et al., 1999, unpublished in
vivo, see Supplementary Data, Figure III). Nestin-Cre,
Flk1loxP/ double transgenic males were crossed with
Flk1loxP/loxP homozygous females to produce Flk1nescre/loxP
offspring. Given the excision specificity of the Nestin-Cre
transgene described previously, these mice are deficient for
Flk1 in the nervous system but heterozygous null in other
cell types. In contrast to the VEGF-Anescre/hypo embryos,
Flk1nescre/null embryos dissected at E13.5 showed no histo-
logical, apoptotic or proliferative abnormalities throughout
the developing CNS (Fig. 8A–F, and data not shown).
Flk1nescre/null mice were born in the normal ratio and showed
no obvious behavioral phenotypes by 1 month of age (data
not shown). Therefore, our analysis has failed to substanti-
ate the putative autocrine role of VEGF-A/Flk1 signaling in
nervous system development in vivo.
Discussion
In this study, we have addressed the specific role of
VEGF-A in the developing nervous system through the
combined use of a conditional gene inactivation approach
and a hypomorphic VEGF-A allele. Through this strategy,
we have been able to investigate how both intermediate and
more severe reductions in VEGF-A levels affect vessel
density in the developing cortex and retina.
The role of VEGF-A in vessel patterning has already
been suggested in studies of VEGF-A isoform knockouts
(Ruhrberg et al., 2002; Stalmans et al., 2002), where alter-
natively spliced exons were either removed or fused with
cDNA fragments to enforce the production of only one of
the three isoforms. In these approaches, changes in
VEGF-A gradients and/or isoform-specific signaling are
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suggested to cause the observed alterations in vascular
patterning. However, in these studies, the effect of
VEGF-A levels is rather difficult to identify since the
removal of two of the three isoforms creates a situation
where the remaining isoform is disproportionately over-
expressed.
Our study demonstrates that both the nervous system-
specific intermediate reduction (VEGF-Anescre/) or inter-
mediate global reduction (VEGF-Ahypo/) of VEGF-A re-
sulted in alterations in vessel density but not diameter. The
branching density in VEGF-Anescre/ and VEGF-Ahypo/
newborns showed approximately 40% reductions, while the
VEGF-Anescre/hypo neonates showed a 90% decrease in the
cortex compared with controls. In contrast to what was
observed in the VEGF-A120/120 embryos (Ruhrberg et al.,
2002), we did not find any differences in vessel diameter in
any of the mutant genotypes examined. This difference
could be attributable to the fact that there is a proportional
overexpression of the VEGF-A120 isoform throughout the
VEGF-A120/120 embryos compared with the wild-type
VEGF-A120 expression levels. However, at present there is
no evidence for isoform-specific VEGF-A signaling being
responsible for distinct responses in the vascular endothe-
lium. A more favorable idea is that the lack of heparin
binding VEGF-A isoforms changes the extracellular distri-
bution of VEGF-A and thereby affects the balance between
migration and proliferation, resulting in increased vessel
diameter (Carmeliet et al., 1999; Ruhrberg et al., 2002).
Simplistically, decreased migration and branching but nor-
mal or increased proliferation would lead to increased ves-
sel diameter, whereas coordinated reduction of migration
and proliferation would merely reduce vessel density. This
idea is in agreement with the effect of reduced levels of
VEGF-A (this study) and with the results of changed iso-
form distribution (Ruhrberg et al., 2002; Stalmans et al.,
2002).
Accordingly, VEGF-A120/120 mice demonstrated reduced
migration of the vasculature into the developing inner reti-
nal layer (2/3 of normal migration distance by P9) (Stal-
mans et al., 2002). Similarly, in the hindbrain, migration
and branching were reduced, whereas proliferation was nor-
mal (Ruhrberg et al., 2002). In contrast, VEGF-A188/188
mice (expressing only VEGF-A188), showed normal vessel
outgrowth but increased capillary network density (Stal-
mans et al., 2002; Ruhrberg et al., 2002). Interestingly,
Ruhrberg et al. (2002) found that the VEGF-A164/164 and the
trans-heterozygous VEGF-A120/188 embryos developed nor-
mal vessel networks. They concluded that isoform specific
signaling is unlikely to be an absolute requirement to spec-
ify proper branching patterns (Ruhrberg et al., 2002). Here,
we show that intermediate and severe reductions in nervous
system VEGF-A activity results in dosage-dependent
changes in vascular density, but not vessel size or rate of
endothelial migration.
Effect of altered vessel density on cortical and retinal
development
Despite altered vessel density and increased hypoxia
throughout the entire developing nervous system, we found
a specific and severe degeneration of the cerebral cortex in
VEGF-Anescre/hypo neonatal mice. VEGF-Anescre/ mice that
have milder reductions in VEGF-A levels show signs of
neuronal acellularity in the cortex and display a retinal
degeneration phenotype that resembles certain forms of
human retinopathies (Ferrara, 2002; Lu and Adamis, 2002;
Smith, 2002). The cortical neuronal degenerative phenotype
in VEGF-Anescre/hypo mice was 100% penetrant, while the
phenotypes in the VEGF-Anescre/ mice varied. The molec-
ular mechanisms responsible for this variability in the
VEGF-Anescre/ mice, and for the specific increase in cor-
tical neuronal apoptosis in the VEGF-Anescre/hypo neonates,
remains to be determined. Hypoxia is likely to be an im-
portant factor, since it is a known modulator of neuronal
apoptosis, and we have documented increased hypoxia
throughout the developing nervous system from E11.5 on-
wards. VEGF-A is one of the best known and characterized
hypoxia regulated genes (Semenza, 2001), showing rapid
and strong upregulation in its expression in both cell culture
settings and in vivo (Semenza, 2001). Compensatory up-
regulation of the wild-type VEGF-A allele due to tissue
hypoxia may have resulted in the variability seen in the
retinal vasculature and cortical phenotypes that we observed
in this study. This could also explain the regional differ-
ences observed for ectopic filopodia extensions. Further-
more, differences in Cre-mediated VEGF-A excision and
strain variance in this outbred system may also contribute to
the observed variability.
Regional differences in the balance of the expression of
pro- and anti-apoptotic genes in the brain can make neurons
differentially vulnerable to hypoxic insults (Banasiak et al.,
2000). This could be a possible explanation for the specific
cortical neuronal apoptosis phenotype observed in develop-
ing VEGF-Anescre/hypo mice. As well, the lack of sprouting
angiogenesis into the VEGF-Anescre/hypo cortex may have
resulted in changes in the expression of specific neurotro-
phic factors (NF) released from the endothelium or other
cell types in the cortex. This decrease in neurotrophic sup-
port would then be responsible for the decreased neuronal
proliferation, aberrant neuronal migration, and increased
neuronal apoptosis that we observed in the ventricular and
subventricular regions of the developing cortex. This hy-
Fig. 7. Histological analysis of the forebrain of wild type (1st column: A, C, E, G) and VEGF-Anescre/hypo (2nd column: B, D, F, H) E15.5 embryos for
cellularity (H&E staining, 1st row, A-B), vascularization (Isolectin-B4 immunofluorescence, 2nd row, C-D), hypoxia (anti-pimonidazole immunohistochem-
istry, 3rd row, E-F), and apoptosis (TUNEL assay, 4th row, G-H). Scale bars represent 50 m.
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pothesis is supported by recent studies examining the role of
the vasculature in neurogenesis in the adult rodent hip-
pocampus and the higher vocal center (HVC) of the adult
songbird neostriatum (Louissaint et al., 2002; Palmer, 2002;
Palmer et al., 2000).
The heterozygous VEGF-Anescre/ mice show obvious
changes in neuronal cellularity in the most superficial layers of
the juvenile cortex. Interestingly, these layers of the cortex
show the highest and most localized levels of cortical VEGF-A
expression (Ogunshola et al., 2000), and we do observe spe-
cific defects in vascular patterning in this region. Given the
above set of experiments, there may be altered neuronal mi-
gration into these layers or increased apoptosis as a result of
changes in factors secreted from the altered microvascular
environment. A summary model of the observed cortical de-
fects observed in this study is presented in Fig. 9.
The autocrine role of VEGF-A/Flk1 in neurogenesis
Due to the severity of the neuronal degeneration ob-
served in VEGF-Anescre/hypo mice, and the recent reports
that VEGF-A may directly influence neuronal proliferation
and differentiation decisions (Hobson et al., 2000; Jin et al.,
2000, 2002; Ogunshola et al., 2002; Oosthuyse et al., 2001),
we have investigated the potential autocrine role of Flk1 in
vivo using a Cre recombinase-dependent Flk1 conditional
allele. Unlike the situation when we conditionally inacti-
vated VEGF-A in the developing neuroectoderm, we have
found no obvious phenotypes in mice lacking Flk1 in the
developing nervous system. These results indicate that Flk1
does not play a direct, essential role in normal nervous
system development. We cannot exclude the possibility that
VEGF-A may still have direct effects on neuronal lineage
development through the stimulation of other VEGF-A re-
ceptors (i.e., Flt1 and Neuropilin-1). Definitive genetic
proof of the direct role of these receptors in VEGF-A
signaling in neuronal development, however, awaits their
nervous system-specific inactivation. With similar strategies
to the one presented here, we expect that the putative,
nonendothelial role of VEGF-A/Flk1 signaling can be ad-
dressed in other organ systems as well, such as in bone and
retinal development (Robinson et al., 2001; Zelzer et al.,
2002).
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